Skip to main content

Table 1 Patient characteristics

From: Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage

Characteristic

Treatment group

P

 

Insulin treatment (n = 24)

No insulin treatment (n = 7)

 

Age (years)

54.0 ± 9.5

46.0 ± 8.7

0.04

Sex (male/female; n)

7/17

1/6

0.44

Clinical presentation (asymptomatic/AFND/DIND; n)

1/14/9

5/0/2

0.03

Admission WFNS score

3.3 ± 1.6

1.6 ± 0.8

0.02

   I (n [%])

5 (21)

4 (57)

 

   II (n [%])

4 (17)

2 (29)

 

   III (n [%])

2 (8)

1 (14)

 

   IV (n [%])

6 (25)

0 (0)

 

   V (n [%])

7 (29)

0 (0)

 

Fisher score

3.7 ± 0.6

3.2 ± 0.8

0.06

Time between SAH and surgery (hours)

14.5 ± 7.8

15.4 ± 7.9

0.72

Duration of microdialysis (hours)

192.6 ± 71.0

295.1 ± 66.4

0.87

Intensive care unit stay (days)

16.8 ± 10.4

12.8 ± 7.8

0.40

  1. Characteristics of 31 subarachnoid haemorrhage (SAH) patients. Data are expressed as mean ± standard deviation or absolute number and percentage; P values are given for between-group comparison of insulin-treated and noninsulin-treated patients (Kruskal-Wallis one-way analysis of variance). WFNS, World Federation of Neurological Surgeons Grading of SAH [21]; AFND, acute focal neurological deficit; DIND, delayed ischemic neurological deficit.